acebutolol has been researched along with Abnormalities, Multiple in 1 studies
Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.
Abnormalities, Multiple: Congenital abnormalities that affect more than one organ or body structure.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Leersnyder, H | 1 |
| Bresson, JL | 1 |
| de Blois, MC | 1 |
| Souberbielle, JC | 1 |
| Mogenet, A | 1 |
| Delhotal-Landes, B | 1 |
| Salefranque, F | 1 |
| Munnich, A | 1 |
1 trial available for acebutolol and Abnormalities, Multiple
| Article | Year |
|---|---|
Beta 1-adrenergic antagonists and melatonin reset the clock and restore sleep in a circadian disorder, Smith-Magenis syndrome.
Topics: Abnormalities, Multiple; Acebutolol; Adolescent; Adrenergic beta-1 Receptor Antagonists; Adrenergic | 2003 |